The United States Food and Drug Administration (FDA), manufacturers of Zantac, and other generic over the counter (OTC) ranitidine drugs have faced significant scrutiny and lawsuits for months. The popular acid-reflux, heartburn and ulcer prevention medication has been labeled as possibly carcinogenic due to its high levels of (NDMA).
Because of the mounting lawsuits, the FDA has recalled all Zantac and generic ranitidine medications. The recall includes prescription and OTC medications. The immediate recall disallows the selling of new, updated or existing Zantac products in the United States.
The recall also comes with a note from the FDA to current users of the medication. The FDA states that any users of Zantac or generic versions of ranitidine cease taking the product stop and consult their physician to discuss other solutions, including approved drugs that produce similar results.
Can Zantac cause prostate cancer?
A New Jersey man believes his use of Zantac three times per week for over five years caused his prostate cancer diagnosis, which led to him filing a lawsuit in the U.S. District Court against the product’s manufacturers. The man’s lawsuit suggests that the NDMA levels in each dose of his medication were thousands of times higher than the FDA’s recommended levels. The lawsuit also stated that exposure to NDMA could lead to damaged and mutated DNA, which causes our DNA chromosomes to separate when they aren’t supposed to, which can lead to the development of cancer.
Have you experienced troubles with Zantac?
Zantac was used by millions of Americans who suffered from symptoms caused by stomach acid. If you feel that your use of Zantac has led to bodily harm, contact an experienced attorney with the experience in handling mass tort cases. Nobody should have to suffer in silence.